Ibere Pharmaceuticals (NYSE:IBER) Shares Up 0.1%

Ibere Pharmaceuticals (NYSE:IBERGet Rating)’s share price was up 0.1% during mid-day trading on Friday . The stock traded as high as $10.01 and last traded at $10.00. Approximately 7,937 shares traded hands during mid-day trading, a decline of 83% from the average daily volume of 47,495 shares. The stock had previously closed at $9.99.

Ibere Pharmaceuticals Stock Up 0.1 %

The company has a 50 day moving average of $9.93 and a two-hundred day moving average of $9.86.

Hedge Funds Weigh In On Ibere Pharmaceuticals

Hedge funds and other institutional investors have recently bought and sold shares of the business. Virtu Financial LLC acquired a new position in shares of Ibere Pharmaceuticals in the 3rd quarter valued at about $250,000. Mizuho Securities USA LLC bought a new stake in Ibere Pharmaceuticals during the third quarter worth about $398,000. Cubist Systematic Strategies LLC acquired a new position in Ibere Pharmaceuticals during the 3rd quarter worth about $698,000. Saba Capital Management L.P. bought a new position in Ibere Pharmaceuticals in the 1st quarter valued at $785,000. Finally, Bank of America Corp DE acquired a new position in Ibere Pharmaceuticals in the first quarter valued at approximately $3,139,000. Institutional investors and hedge funds own 71.43% of the company’s stock.

About Ibere Pharmaceuticals

(Get Rating)

Ibere Pharmaceuticals does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Philadelphia, Pennsylvania.

Featured Stories

Receive News & Ratings for Ibere Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ibere Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.